Drugs / Sodium Laural Sulfate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01112787 Comparator | Mar → Apr 2010 | acne | Stiefel, a GSK Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Laural Sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01112787 ↗ |
| Route | Topical | “Subjects will be exposed to patches containing Sodium Laural Sulfate.” NCT01112787 ↗ |